Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2025-12-24 @ 4:02 PM
NCT ID: NCT00309166
Eligibility Criteria: Inclusion criteria: * A male between, and including, 10 and 18 years of age at the time of the first vaccination. * Written informed consent obtained from the subject prior to enrolment * For subjects below the legal age of consent, a written informed consent must be obtained from the subject's parent/guardian. In addition, a written informed assent must be obtained from the subject. * Healthy subjects as established by medical history and clinical examination before entering into the study. * Free of obvious health problems as established by medical history and clinical examination before entering into the study. Exclusion criteria: * Previous vaccination against Human Papillomavirus (HPV). * Previous vaccination against Hepatitis B, known clinical history of Hepatitis B infection. * Cancer or autoimmune disease under treatment.
Healthy Volunteers: True
Sex: MALE
Minimum Age: 10 Years
Maximum Age: 18 Years
Study: NCT00309166
Study Brief:
Protocol Section: NCT00309166